Envestnet Asset Management’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.22M Buy
17,177
+2,491
+17% +$358K ﹤0.01% 2942
2025
Q4
$2.1M Sell
14,686
-2,266
-13% -$304K ﹤0.01% 2789
2025
Q3
$2.03M Sell
16,952
-2,412
-12% -$306K ﹤0.01% 2869
2025
Q2
$2.56M Sell
19,364
-905
-4% -$123K ﹤0.01% 2656
2025
Q1
$2.81M Buy
20,269
+1,534
+8% +$238K ﹤0.01% 2501
2024
Q4
$2.91M Sell
18,735
-355
-2% -$60K ﹤0.01% 2462
2024
Q3
$3.48M Buy
19,090
+433
+2% +$64.1K ﹤0.01% 2332
2024
Q2
$2.22M Buy
18,657
+1,336
+8% +$141K ﹤0.01% 2532
2024
Q1
$1.86M Buy
17,321
+7,270
+72% +$723K ﹤0.01% 2616
2023
Q4
$1M Sell
10,051
-3,149
-24% -$308K ﹤0.01% 2935
2023
Q3
$1.57M Buy
13,200
+3,669
+38% +$547K ﹤0.01% 2509
2023
Q2
$1.7M Buy
9,531
+1,132
+13% +$208K ﹤0.01% 2374
2023
Q1
$1.39M Buy
8,399
+989
+13% +$170K ﹤0.01% 2437
2022
Q4
$1.17M Sell
7,410
-800
-10% -$122K ﹤0.01% 2519
2022
Q3
$1.24M Sell
8,210
-475
-5% -$79K ﹤0.01% 2395
2022
Q2
$1.43M Sell
8,685
-700
-7% -$135K ﹤0.01% 2331
2022
Q1
$2.09M Buy
9,385
+1,253
+15% +$281K ﹤0.01% 2170
2021
Q4
$1.93M Sell
8,132
-23
-0.3% -$5.37K ﹤0.01% 2210
2021
Q3
$1.9M Sell
8,155
-998
-11% -$209K ﹤0.01% 2118
2021
Q2
$1.88M Sell
9,153
-9
-0.1% -$1.85K ﹤0.01% 2099
2021
Q1
$1.88M Buy
9,162
+169
+2% +$35.7K ﹤0.01% 1976
2020
Q4
$1.93M Sell
8,993
-354
-4% -$68.7K ﹤0.01% 1778
2020
Q3
$1.71M Sell
9,347
-8,940
-49% -$1.68M ﹤0.01% 1706
2020
Q2
$3.37M Sell
18,287
-4,476
-20% -$889K ﹤0.01% 1313
2020
Q1
$4.59M Buy
22,763
+1,676
+8% +$323K 0.01% 1034
2019
Q4
$3.95M Sell
21,087
-429
-2% -$73.8K ﹤0.01% 1257
2019
Q3
$3.43M Sell
21,516
-779
-3% -$155K ﹤0.01% 1249
2019
Q2
$5.62M Buy
22,295
+1,037
+5% +$240K 0.01% 990
2019
Q1
$5.09M Buy
21,258
+2,164
+11% +$519K 0.01% 983
2018
Q4
$4.38M Buy
+19,094
New +$4.71M 0.01% 947
2018
Q3
Sell
-4,169
Closed -$1.22M 1885
2018
Q2
$1.22M Sell
4,169
-225
-5% -$61.5K ﹤0.01% 983
2018
Q1
$1.11M Sell
4,394
-4,949
-53% -$1.16M ﹤0.01% 905
2017
Q4
$2.02M Sell
9,343
-1,157
-11% -$234K ﹤0.01% 947
2017
Q3
$1.95M Sell
10,500
-330
-3% -$57.5K ﹤0.01% 915
2017
Q2
$1.87M Buy
10,830
+2,043
+23% +$328K 0.01% 957
2017
Q1
$1.34M Sell
8,787
-624
-7% -$91.2K ﹤0.01% 1098
2016
Q4
$1.38M Sell
9,411
-218
-2% -$31.6K 0.01% 1070
2016
Q3
$1.22M Sell
9,629
-2,128
-18% -$257K ﹤0.01% 1158
2016
Q2
$1.33M Buy
11,757
+320
+3% +$33.2K 0.01% 1204
2016
Q1
$1.19M Buy
11,437
+832
+8% +$79.5K 0.01% 1229
2015
Q4
$1.2M Buy
10,605
+1,832
+21% +$202K 0.01% 1201
2015
Q3
$961K Sell
8,773
-254
-3% -$27.2K ﹤0.01% 1288
2015
Q2
$864K Buy
9,027
+112
+1% +$10.5K ﹤0.01% 1465
2015
Q1
$830K Buy
8,915
+8,846
+12,820% +$774K ﹤0.01% 1362
2014
Q4
$6K Sell
69
-29
-30% -$2.22K ﹤0.01% 2081
2014
Q3
$6K Hold
98
﹤0.01% 2263
2014
Q2
$6K Hold
98
﹤0.01% 2226
2014
Q1
$6K Sell
98
-84
-46% -$5.17K ﹤0.01% 2049
2013
Q4
$12K Sell
182
-2
-1% -$129 ﹤0.01% 1671
2013
Q3
$12K Buy
184
+18
+11% +$1.28K ﹤0.01% 1640
2013
Q2
$12K Buy
+166
New +$11K ﹤0.01% 1601

Other funds holding ICUI

Envestnet Asset Management's ICUI Position: Q1 2026 in Review

Envestnet Asset Management increased its ICU Medical (ICUI) stake by 17% in Q1 2026, buying an estimated $358K and bringing the position to 17,177 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2942.

Envestnet Asset Management first reported a position in ICUI in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.62M in Q2 2019. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Envestnet Asset Management held 17,177 shares of ICU Medical worth $2.22M as of Q1 2026.
  • Envestnet Asset Management bought 2,491 ICU Medical shares in Q1 2026, an estimated $358K.
  • ICU Medical made up ﹤0.01% of Envestnet Asset Management's portfolio in Q1 2026, its #2942 holding.
  • Envestnet Asset Management first reported a position in ICU Medical in Q2 2013 and has held it in 51 quarters since.
  • Envestnet Asset Management's ICU Medical position peaked at $5.62M in Q2 2019.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.